Market capitalization | JPY1.95t |
Enterprise Value | JPY1.68t |
P/E (TTM) P/E ratio | 11.55 |
EV/FCF (TTM) EV/FCF | 8.63 |
EV/Sales (TTM) EV/Sales | 3.89 |
P/S ratio (TTM) P/S ratio | 4.50 |
P/B ratio (TTM) P/B ratio | 1.45 |
Dividend yield | 2.51% |
Last dividend (FY25) | JPY57.33 |
As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.
13 Analysts have issued a Shionogi & forecast:
13 Analysts have issued a Shionogi & forecast:
Dec '24 |
+/-
%
|
||
Revenue | 431,861 431,861 |
2%
2%
|
|
Gross Profit | 366,265 366,265 |
1%
1%
|
|
EBITDA | 176,246 176,246 |
2%
2%
|
EBIT (Operating Income) EBIT | 155,635 155,635 |
4%
4%
|
Net Profit | 168,610 168,610 |
9%
9%
|
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.
Head office | Japan |
CEO | Isao Teshirogi |
Employees | 4,959 |
Founded | 1878 |
Website | www.shionogi.co.jp |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.